FSMAX
Price
$98.68
Change
-$2.68 (-2.64%)
Updated
Nov 13 closing price
Net Assets
41.46B
PSKCX
Price
$43.32
Change
-$1.27 (-2.85%)
Updated
Nov 13 closing price
Net Assets
874.73M
Interact to see
Advertisement

FSMAX vs PSKCX

Header iconFSMAX vs PSKCX Comparison
Open Charts FSMAX vs PSKCXBanner chart's image
Fidelity Extended Market Index
Price$98.68
Change-$2.68 (-2.64%)
VolumeN/A
Net Assets41.46B
Virtus KAR Mid-Cap Growth C
Price$43.32
Change-$1.27 (-2.85%)
VolumeN/A
Net Assets874.73M
FSMAX vs PSKCX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. PSKCX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and PSKCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.5B vs. PSKCX (875M). FSMAX pays higher dividends than PSKCX: FSMAX (0.43) vs PSKCX (0.00). FSMAX was incepted earlier than PSKCX: FSMAX (14 years) vs PSKCX (25 years). PSKCX (2.04) is less costly to investors than FSMAX (0.04). FSMAX is a more actively managed with annual turnover of: 15.00 vs. PSKCX (13.00). FSMAX has a lower initial minimum investment than PSKCX: FSMAX (0) vs PSKCX (2500). FSMAX annual gain was more profitable for investors over the last year : 6.78 vs. PSKCX (-4.46). FSMAX return over 5 years is better than : 44.78 vs. PSKCX (-8.27).
FSMAXPSKCXFSMAX / PSKCX
Total Expense Ratio0.042.042%
Annual Report Gross Expense Ratio0.042.042%
Fund Existence14 years25 years-
Gain YTD11.5980.6321,835%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets41.5B875M4,743%
Annual Yield % from dividends0.430.00-
Returns for 1 year6.78-4.46-152%
Returns for 3 years53.3021.80245%
Returns for 5 years44.78-8.27-541%
Returns for 10 years108.36149.3873%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GANX2.950.27
+10.07%
Gain Therapeutics
MSIF12.230.15
+1.24%
MSC Income Fund Inc.
LOGI121.131.16
+0.97%
Logitech International SA
ALBT2.000.01
+0.50%
Avalon GloboCare Corp
WB10.57-0.14
-1.31%
Weibo Corp